target

Juno Therapeutics

bidder

Celgene Corporation

£5,862m

60 dealmakers

target

Kite Pharma

bidder

Gilead Sciences

£9,302m

24 dealmakers

target

Wework Companies

bidder

Softbank Group Corp

value n/a

16 dealmakers

target

Webroot

bidder

Carbonite

£477m

19 dealmakers

target

Clementia Pharmaceuticals

bidder

IPSEN

£995m

41 dealmakers

target

Nightstar Therapeutics

bidder

Biogen

£663m

30 dealmakers

target

Array Biopharma

bidder

Pfizer

£9,049m

51 dealmakers

target

Galapagos

bidder

Gilead Sciences

£849m

36 dealmakers

target

Semma Therapeutics

bidder

Vertex Pharmaceuticals

£785m

26 dealmakers

target

Alder Biopharmaceuticals

bidder

Lundbeck As

£1,559m

10 dealmakers

target

Bioverativ

bidder

Sanofi

£7,852m

45 dealmakers

target

Achillion Pharmaceuticals

bidder

Alexion Pharmaceuticals

£732m

21 dealmakers

target

Carbonite

bidder

OPENTEXT

£1,110m

47 dealmakers

target

Arqule

bidder

Merck Kgaa

£2,054m

62 dealmakers

target

Wework Companies

bidder

Softbank Group Corp

£3,472m

33 dealmakers

target

Legg Mason

bidder

Franklin Templeton Investments Corporation

£4,990m

63 dealmakers

target

Forty Seven

bidder

Gilead Sciences

£3,821m

48 dealmakers

target

Stemline Therapeutics

bidder

Menarini Group

£541m

44 dealmakers

target

Portola Pharmaceuticals

bidder

Alexion Pharmaceuticals

£1,306m

50 dealmakers

target

Momenta Pharmaceuticals

bidder

Johnson & Johnson

£4,929m

57 dealmakers

target

Cersci Therapeutics

bidder

Acadia Pharmaceuticals

£717m

20 dealmakers

target

Akcea Therapeutics

bidder

Ionis Pharmaceuticals

£334m

36 dealmakers

target

Wework China

bidder

Trustbridge Partners

£157m

14 dealmakers

target

Urovant Sciences

bidder

Sumitovant Biopharma

£144m

13 dealmakers

target

Boston Dynamics

bidder

Hyundai Motor Group

£695m

34 dealmakers

target

National Holdings

bidder

B. Riley Financial

value n/a

24 dealmakers

target

Gw Pharmaceuticals

bidder

Jazz Pharmaceuticals

£5,266m

85 dealmakers

target

Pandion Therapeutics

bidder

Merck & Co

£1,308m

28 dealmakers

target

Five Prime Therapeutics

bidder

Amgen

£1,361m

34 dealmakers

target

Wework Companies

bidder

Bow Capital

£6,532m

107 dealmakers

target

STRONGBRIDGE

bidder

Xeris Pharmaceuticals

£188m

53 dealmakers

target

Constellation Pharmaceuticals

bidder

Morphosys

£1,198m

58 dealmakers

target

Translate Bio

bidder

Sanofi

£2,302m

52 dealmakers

target

Amicus Therapeutics (gene Therapy Business)

bidder

Arya Sciences Acquisition Corp Iv

£440m

25 dealmakers

target

Acceleron Pharma

bidder

Merck & Co

£8,528m

80 dealmakers

target

Aspen Technology

bidder

Emerson Electric Co

£8,081m

49 dealmakers

target

DICERNA

bidder

Novo Nordisk

£2,452m

23 dealmakers

target

BOTTOMLINE

bidder

Thoma Bravo

£1,956m

30 dealmakers

target

Sierra Oncology

bidder

Glaxosmithkline

£1,522m

20 dealmakers

target

Antares Pharma

bidder

HALOZYME

£737m

59 dealmakers

target

Biohaven Pharmaceutical Holding Company

bidder

Pfizer

£9,417m

45 dealmakers

target

VIACYTE

bidder

Vertex Pharmaceuticals

£265m

42 dealmakers

target

Aerie Pharmaceuticals

bidder

Alcon

£650m

58 dealmakers

target

Cincor Pharma

bidder

Astrazeneca

£1,487m

79 dealmakers

target

Seagen

bidder

Pfizer

£35,705m

67 dealmakers

target

Prometheus Biosciences

bidder

Merck & Co

£8,698m

50 dealmakers

target

Bellus Health

bidder

Glaxosmithkline

£1,614m

17 dealmakers

target

Iveric Bio

bidder

Astellas Pharma

£4,693m

22 dealmakers

target

Cti Biopharma

bidder

Swedish Orphan Biovitrum (sobi)

£1,347m

76 dealmakers

target

Intercept Pharmaceuticals

bidder

Alfasigma

£649m

31 dealmakers

target

Point Biopharma

bidder

Eli Lilly And Company

£1,152m

40 dealmakers

target

Mirati Therapeutics

bidder

Bristol Myers Squibb Company

£3,840m

54 dealmakers

target

ENGAGESMART

bidder

Vista Equity Partners

£3,288m

48 dealmakers

target

Cerevel Therapeutics

bidder

Abbvie

£6,894m

53 dealmakers

target

Ambrx

bidder

Johnson & Johnson

£1,493m

38 dealmakers

target

Morphosys

bidder

Novartis

£2,309m

100 dealmakers

target

Cymabay Therapeutics

bidder

Gilead Sciences

£3,404m

30 dealmakers

target

Alpine Immune Sciences

bidder

Vertex Pharmaceuticals

£3,867m

54 dealmakers

target

INHIBRX

bidder

Sanofi

£1,337m

58 dealmakers

target

EYEBIOTECH

bidder

Merck & Co

£2,348m

23 dealmakers

target

23andme

bidder

Anne Wojcicki

value n/a

3 dealmakers